Clareo Health | Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Nīmes
The secondary objectives of this study are:
A. To estimate the average calcium intake and variability in a population of MS patients and the proportion of patients at risk for osteoporosis.
B. To estimate the average calcium intake and variability in a population of CIA patients and the proportion of patients at risk for osteoporosis.
C. To describe the dietary changes observed in MS or CIA patients .
D. To estimate the administration time of the QALCIMUM® self-questionnaire.
E. Estimate calcium intake means and variability in a population of patients with MS or CIA and the proportion of patients at risk of osteoporotic fracture
F. To assess the quality of life of patients with MS or CIA
G. To evaluate endogenous mean vitamin D production in a population of patients with MS or CIA
Age
18–69
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The patient must have given his/her informed and signed consent
The patient must be insured or beneficiary of a health insurance plan
Patient with confirmed diagnosis of multiple sclerosis or chronic inflammatory arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis)
You may not be if
The patient is participating in another biomedical research study
The patient has participated in another biomedical research study in the past 3 months
The patient is in an exclusion period determined by a previous study
The patient is under judicial protection, or under guardianship
The patient refuses to sign the consent
It is impossible to correctly inform the patient
The subject is not able to complete a self-administered questionnaire
